Abstract
Background and Objective: Hydroxychloroquine (HCQ) is a molecule derived from quinacrine; it displays a wide range of pharmacological properties, including anti-inflammatory, immunomodulatory, and antineoplastic. However, little is known about this molecule’s role in lung injury. This study aimed to identify HCQ’s regulatory role of HCQ in sepsis-induced lung injury and its molecular mechanism. Methods: To test the protective properties of HCQ, we established an in vivo model of lipopolysaccharide (LPS)-induced lung injury in mice. The extent of the injury was determined by evaluating histopathology, inflammatory response, oxidative stress, and apoptosis. Mechanistically, conventional nucleotide-binding oligomerization domain leucine-rich repeat and pyrin domain-containing 3 (NLRP3) knockout mice were employed to investigate whether HCQ exerted pulmonary protection by inhibiting NLRP3-mediated pyroptosis.
Results: Our findings revealed that HCQ pretreatment significantly mitigated LPS-induced lung injury in mice in terms of histopathology, inflammatory response, oxidative stress, and apoptosis, while inhibiting LPS-induced NLRP3 inflammasome activation and pyroptosis. Additionally, the indicators of lung injury, including histopathology, inflammatory response, oxidative stress, and apoptosis, were still reduced drastically in LPS-treated NLRP3 (-/-) mice after HCQ pretreatment. Notably, HCQ pretreatment further decreased the levels of pyroptosis indicators, including IL-1β, IL-18 and Cle-GSDMD, in LPS-treated NLRP3 (-/-) mice.
Conclusion: Taken together, HCQ protects against lung injury by inhibiting pyroptosis, maybe not only through the NLRP3 pathway but also through non-NLRP3 pathway; therefore, it may be a new therapeutic strategy in the treatment of lung injury.
Keywords: Hydroxychloroquine, lung injury, NLRP3, pyroptosis inflammation, oxidative stress, apoptosis
Graphical Abstract
[http://dx.doi.org/10.1164/rccm.201001-0024WS] [PMID: 20224063]
[http://dx.doi.org/10.1186/s13054-019-2339-3] [PMID: 30760290]
[http://dx.doi.org/10.1016/j.ejphar.2017.10.029] [PMID: 29054740]
[http://dx.doi.org/10.1002/jcp.26274] [PMID: 29150939]
[http://dx.doi.org/10.1016/j.tibs.2016.10.004] [PMID: 27932073]
[http://dx.doi.org/10.3892/mmr.2021.11865] [PMID: 33495843]
[http://dx.doi.org/10.1155/2020/8351342] [PMID: 32190178]
[http://dx.doi.org/10.1007/s10753-019-00990-7] [PMID: 30887396]
[http://dx.doi.org/10.1146/annurev-cellbio-101011-155745] [PMID: 22974247]
[http://dx.doi.org/10.1038/nature15514] [PMID: 26375003]
[http://dx.doi.org/10.1177/0961203396005001021] [PMID: 8803902]
[http://dx.doi.org/10.3390/molecules26010175] [PMID: 33396545]
[http://dx.doi.org/10.1111/ajd.13168] [PMID: 31612996]
[http://dx.doi.org/10.1038/s41419-018-0378-3] [PMID: 29500339]
[http://dx.doi.org/10.1186/s13075-019-2040-6] [PMID: 31775905]
[http://dx.doi.org/10.1002/ctm2.228] [PMID: 33252860]
[http://dx.doi.org/10.1124/jpet.116.239087] [PMID: 28123046]
[http://dx.doi.org/10.1016/j.surg.2018.12.018] [PMID: 30824287]
[http://dx.doi.org/10.1016/j.redox.2019.101215] [PMID: 31121492]
[http://dx.doi.org/10.1172/JCI60331] [PMID: 22850883]
[http://dx.doi.org/10.2147/JIR.S304492] [PMID: 34103962]
[http://dx.doi.org/10.1016/j.tox.2020.152627] [PMID: 33161053]
[http://dx.doi.org/10.21037/apm-20-1138] [PMID: 32692236]
[http://dx.doi.org/10.1155/2019/4848560] [PMID: 31565151]
[http://dx.doi.org/10.1016/j.freeradbiomed.2020.02.032] [PMID: 32131025]
[http://dx.doi.org/10.15252/embj.2020106700] [PMID: 33439509]
[http://dx.doi.org/10.1111/jpi.12322] [PMID: 26888116]
[http://dx.doi.org/10.1080/08958378.2019.1668091] [PMID: 31556748]
[http://dx.doi.org/10.1186/s13046-018-0938-5] [PMID: 30373678]
[http://dx.doi.org/10.1038/s41598-017-11450-3] [PMID: 28878315]
[PMID: 33293167]
[http://dx.doi.org/10.1016/j.exger.2019.110661] [PMID: 31319131]